AbbVie to 'commit less capital' towards psychiatric drugs, CEO says-March 2024-www.financetom.com

AbbVie to 'commit less capital' towards psychiatric drugs, CEO says

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

AbbVie to 'commit less capital' towards psychiatric drugs, CEO says

Jan 15, 2025 9:28 AM

Jan 15 (Reuters) - AbbVie ( ABBV ) will commit less capital towards experimental

medicines for psychiatric disease, CEO Robert Michael said at an industry conference on

Wednesday.

The remarks come months after experimental schizophrenia drug failed in two mid-stage

studies.

Previous page： Crawford United Corp Q3 sales rise 28.4% on strong demand Next page： Spotify forecasts profit above estimates on user growth, price hikes

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Crawford United Corp Q3 sales rise 28.4% on strong demand

Nov 4, 2025

Overview * Crawford United ( CRAWA ) Q3 sales rose 28.4% yr/yr to $47.2 mln * Net income for Q3 increased 60.4% to $5.4 mln * EPS for Q3 was $1.52, reflecting strong performance Result Drivers * SALES GROWTH - Sales increased 28.4% to $47.2 mln, driven by strong demand across business segments * RECORD NET INCOME - Net income...

Spotify forecasts profit above estimates on user growth, price hikes

Nov 4, 2025

(Reuters) -Spotify ( SPOT ) forecast fourth-quarter profit above Wall Street expectations on Tuesday, betting on robust user growth and a boost from price hikes in the crucial holiday season. Shares of the company, which competes with Apple and Amazon's music streaming offerings, rose 5.3% in premarket trading. The Swedish streaming giant has raised prices of its premium individual subscription...

ADM cuts 2025 profit outlook on weaker crush margins

Nov 4, 2025

(Reuters) -Archer-Daniels-Midland Co ( ADM ) on Tuesday lowered its full-year 2025 earnings forecast, citing weaker crush margins and a delay in U.S. biofuel policy, sending the grain trader's shares down 8.5% in premarket trading. ADM now expects adjusted earnings of $3.25 to $3.50 per share for 2025, down from its earlier forecast of around $4.00. However, the company said...

Patria Q3 EPS beats estimates, AUM surpasses $50 bln

Nov 4, 2025

Overview * Patria Q3 adjusted EPS of $0.30 beats analyst expectations * Adjusted net income for Q3 was $46.9 mln, exceeding analyst estimates * Patria's AUM surpasses $50 bln, marking significant growth since IPO Outlook * Patria on track to exceed full-year fundraising target of $6.6 bln * Company confident in meeting 2025 targets and 2026-2027 objectives Result Drivers *...